Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly i » significantly _ (Expand Search), significantly high (Expand Search), significantly less (Expand Search)
i decrease » _ decrease (Expand Search), a decrease (Expand Search), _ decreased (Expand Search)
Showing 2,841 - 2,860 results of 21,342 for search '(( significantly i decrease ) OR ( significant decrease decrease ))', query time: 0.53s Refine Results
  1. 2841
    Chlorophyll fluorescence: (A) Yield - quantum yield of the photochemical reaction in PSII, (C) ETR – electron transport rate, (E) NPQ - Non - Photochemical Quenching, (B) F0 - initial fluorescence, (D) Fm - maximum fluorescence, (F) Fv/Fm - maximum photochemical efficiency of PSII.

    Chlorophyll fluorescence: (A) Yield - quantum yield of the photochemical reaction in PSII, (C) ETR – electron transport rate, (E) NPQ - Non - Photochemical Quenching, (B) F0 - init... by Dominika Radzikowska-Kujawska (14439076)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2842
    Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis

    Supplementary Material for: Significant Dry Weight Reduction After Transition from Peritoneal Dialysis to Hemodialysis by Lin Y.-T. (17065287)

    Published 2025
    “…After transitioning to HD, body weight decreased significantly, with a reduction of -2.8 kg at one month, -5.3 kg at three months, and -7.5 kg one year post-transition. …”
    Save to List
    Saved in:
  3. 2843
    Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).

    Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells). by Andrey V. Cybulsky (4007012)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 2844
    Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA.

    Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2845
    Antimicrobial Activity of Glycyrrhizinic Acid Is pH-Dependent

    Antimicrobial Activity of Glycyrrhizinic Acid Is pH-Dependent by Mathieu Joos (20331128)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 2846
    Forest plot of the improvement in primary endpoints.

    Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2847
    Subgroup and sensitivity analyses for the primary outcomes.

    Subgroup and sensitivity analyses for the primary outcomes. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2848
    Forest plot of inflammatory markers.

    Forest plot of inflammatory markers. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2849
    Flow diagram for the identification of studies included.

    Flow diagram for the identification of studies included. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2850
    Forest plot of the hospital stay length in distinct stages of patients.

    Forest plot of the hospital stay length in distinct stages of patients. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2851
    Forest plot of the second endpoint of the clinical symptom improvement.

    Forest plot of the second endpoint of the clinical symptom improvement. by Jin-Min Gu (17915039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2852
    Enrichment analysis of genes from the significant MS module.

    Enrichment analysis of genes from the significant MS module. by Lai Jiang (2401513)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2853
    Results of cost-effectiveness analysis of <i>Chuna</i> manual therapy compared with usual care<sup>a</sup>.

    Results of cost-effectiveness analysis of <i>Chuna</i> manual therapy compared with usual care<sup>a</sup>. by Jae-Heung Cho (798319)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2854
    Main baseline characteristics of patients included in the study.

    Main baseline characteristics of patients included in the study. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2855
    (A) Monthly drug costs of patients in the ESAs group and Roxadustat group.

    (A) Monthly drug costs of patients in the ESAs group and Roxadustat group. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2856
    Study data.

    Study data. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2857
    Mean hemoglobin levels of Roxadustat and ESAs groups over time.

    Mean hemoglobin levels of Roxadustat and ESAs groups over time. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2858
    Morisky score for ESAs group and Roxadustat group.

    Morisky score for ESAs group and Roxadustat group. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2859
    Patient flow diagram.

    Patient flow diagram. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2860
    Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup.

    Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: